Research Studies » Moderately to Severely Active Crohn's Disease

Moderately to Severely Active Crohn's Disease

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of ABBV-154 in Subjects with Moderately to Severely Active Crohn's Disease (CD)

Powered By RealTime-CTMS Clinical Trial Management System